Carcinogenic nickel silences gene expression by chromatin condensation and DNA methylation: a new model for epigenetic carcinogens.

Molecular and Cellular Biology
Y W LeeM Costa

Abstract

A transgenic gpt+ Chinese hamster cell line (G12) was found to be susceptible to carcinogenic nickel-induced inactivation of gpt expression without mutagenesis or deletion of the transgene. Many nickel-induced 6-thioguanine-resistant variants spontaneously reverted to actively express gpt, as indicated by both reversion assays and direct enzyme measurements. Since reversion was enhanced in many of the nickel-induced variant cell lines following 24-h treatment with the demethylating agent 5-azacytidine, the involvement of DNA methylation in silencing gpt expression was suspected. This was confirmed by demonstrations of increased DNA methylation, as well as by evidence indicating condensed chromatin and heterochromatinization of the gpt integration site in 6-thioguanine-resistant cells. Upon reversion to active gpt expression, DNA methylation and condensation are lost. We propose that DNA condensation and methylation result in heterochromatinization of the gpt sequence with subsequent inheritance of the now silenced gene. This mechanism is supported by direct evidence showing that acute nickel treatment of cultured cells, and of isolated nuclei in vitro, can indeed facilitate gpt sequence-specific chromatin condensation. Epigenet...Continue Reading

References

Nov 1, 1992·Human Molecular Genetics·R S HansenC D Laird
Sep 1, 1992·Human Molecular Genetics·J S SutcliffeS T Warren
Dec 1, 1992·Molecular and Cellular Biology·M PikaartB Villeponteau
May 1, 1992·Trends in Genetics : TIG·A D Riggs, G P Pfeifer
Jul 10, 1992·Cell·A Bird
May 24, 1990·Biochimica Et Biophysica Acta·H Cedar, A Razin
Jan 1, 1991·Annual Review of Pharmacology and Toxicology·M Costa
Mar 1, 1990·Trends in Biochemical Sciences·E U Selker
Jan 1, 1990·Environmental and Molecular Mutagenesis·C B Klein, T G Rossman
Mar 1, 1989·Biochimica Et Biophysica Acta·J G Tasseron-de JongM Giphart-Gassler
Aug 11, 1989·Cell·F AntequeraA P Bird
Apr 14, 1989·Science·B VogelsteinR White
Oct 9, 1987·Science·R Holliday
Mar 1, 1981·Proceedings of the National Academy of Sciences of the United States of America·M Behe, G Felsenfeld
Dec 20, 1983·Nucleic Acids Research·K K RichardsonT R Skopek
Apr 11, 1984·Nucleic Acids Research·N BorochovH Eisenberg
Jun 1, 1983·Experimental Cell Research·A Weith
Jan 1, 1994·Human Molecular Genetics·P W Laird, R Jaenisch
Oct 11, 1994·Proceedings of the National Academy of Sciences of the United States of America·J G HermanW M Linehan
Jun 6, 1994·The Science of the Total Environment·M CostaK Salnikow
Jun 7, 1994·Proceedings of the National Academy of Sciences of the United States of America·K R Cook, G H Karpen
Apr 1, 1994·Current Opinion in Genetics & Development·G H Karpen
Jun 1, 1993·Nature Genetics·A P Feinberg

❮ Previous
Next ❯

Citations

Dec 18, 2015·Journal of Immunotoxicology·Brian C TookerLee S Newman
Apr 19, 2011·Toxicology Mechanisms and Methods·Domniki FragouLeda Kovatsi
Dec 3, 2014·Clinica Chimica Acta; International Journal of Clinical Chemistry·Sham Kumar Wadhwa Naeemullah
Sep 24, 2014·Proceedings of the National Academy of Sciences of the United States of America·Cynthia C JoseSuresh Cuddapah
Apr 2, 2013·International Journal of Hygiene and Environmental Health·Preeyaporn KoedrithYoung Rok Seo
Nov 6, 2002·Japanese Journal of Cancer Research : Gann·Naoki YanagawaTeiichi Motoyama
May 29, 2012·Journal of Trace Elements in Medicine and Biology : Organ of the Society for Minerals and Trace Elements (GMS)·Adriana AritaMax Costa
Oct 16, 2012·Translational Oncology·Dmitry A OvchinnikovChamindie Punyadeera
May 11, 2010·Journal of Pharmacological and Toxicological Methods·Anthony R CalabroFrank A Barile
Mar 18, 2010·The Journal of Nutritional Biochemistry·Valerio CostaAlfredo Ciccodicola
Dec 5, 2015·Biophysical Journal·Ji YiVadim Backman
Apr 18, 2009·Toxicology and Applied Pharmacology·Xue ZhouMax Costa
Jan 6, 2009·American Journal of Orthodontics and Dentofacial Orthopedics : Official Publication of the American Association of Orthodontists, Its Constituent Societies, and the American Board of Orthodontics·Evangelia PetoumenouChristoph Bourauel
Jun 12, 2009·Developmental Dynamics : an Official Publication of the American Association of Anatomists·Cavit AgcaJudith M Venuti
Jan 6, 2010·Wiley Interdisciplinary Reviews. Nanomedicine and Nanobiotechnology·Vanesa C SanchezAgnes B Kane
May 2, 2003·Annals of the New York Academy of Sciences·Lee E MooreRichard B Hayes
May 2, 2003·Annals of the New York Academy of Sciences·Jessica E Sutherland, Max Costa
Mar 1, 1997·Toxicology and Applied Pharmacology·A R OllerG Oberdörster
Apr 20, 2006·Ecotoxicology and Environmental Safety·Ashok SinghSrikanta Kumar Rath
Aug 6, 2005·Mutation Research·Iain B LambertGeorge R Douglas
Jul 13, 2005·Mutation Research·Max CostaThomas Kluz
Jul 5, 2005·Comptes rendus biologies·Najla HfaïedhAbdelfattah El Feki
May 1, 2015·Environmental Science and Pollution Research International·İlker ÇelenMurat Lekili
Jan 19, 2012·International Journal of Epidemiology·Lifang HouAndrea Baccarelli
Apr 10, 2013·Toxicology and Applied Pharmacology·Victor C WongAnatoly Zhitkovich
Sep 10, 2013·Clinica Chimica Acta; International Journal of Clinical Chemistry·Hassan Imran AfridiSumsun Naher
Jan 3, 2012·Toxicology in Vitro : an International Journal Published in Association with BIBRA·S GiuntaV D'Agata
Jun 4, 2015·American Journal of Orthodontics and Dentofacial Orthopedics : Official Publication of the American Association of Orthodontists, Its Constituent Societies, and the American Board of Orthodontics·Mohammad Ali SaghiriNader Sheibani
May 20, 2014·Journal of Trace Elements in Medicine and Biology : Organ of the Society for Minerals and Trace Elements (GMS)·Jason Brocato, Max Costa
May 20, 2015·Clinical Epigenetics·Adrian Ruiz-HernandezMaria Tellez-Plaza
Dec 31, 2014·Environmental Science and Pollution Research International·Tasneem Gul KaziJameel Ahmed Baig
Mar 30, 1999·Experimental Cell Research·M W McBurney
Jul 10, 2012·Molecular Aspects of Medicine·Covadonga HuidobroMario F Fraga
Nov 5, 2014·Frontiers in Cell and Developmental Biology·Riya R KanherkarAntonei B Csoka
Oct 17, 2015·PloS One·Li MaNing Cheng

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cancer Epigenetics and Chromatin (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. The epigenetic changes may or may not provide advantages for the cancer cells. This feed focuses on chromatin and its role in cancer epigenetics please follow this feed to learn more.

Cell Signaling & Cancer Epigenetics (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. This feed covers the latest research on signaling and epigenetics in cell growth and cancer.

Cancer Epigenetics (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. The epigenetic changes may or may not provide advantages for the cancer cells. Here is the latest research on cancer epigenetics.

Cancer Epigenetics Chromatin Complexes (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. The epigenetic changes may or may not provide advantages for the cancer cells. This feed focuses on chromatin complexes and their role in cancer epigenetics.

Cancer Epigenetics & Methyl-CpG (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. Here is the latest research on cancer epigenetics and methyl-CpG binding proteins including ZBTB38.

Cancer Epigenetics

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. The epigenetic changes may or may not provide advantages for the cancer cells. Here is the latest research on cancer epigenetics.

Cancer Epigenetics and Senescence (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. The epigenetic changes may be involved in regulating senescence in cancer cells. This feed captures the latest research on cancer epigenetics and senescence.

Cancer Epigenetics & Metabolism (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. The epigenetic changes may or may not provide advantages for the cancer cells. This feed focuses on the relationship between cell metabolism, epigenetics and tumor differentiation.